← Open Payments lookup

MATTHEW TAYLOR: Open Payments

NPI 1831722271 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,756 in 98 payments from 17 companies in 2025. Trend: 2023 $2,724 · 2024 $2,519 · 2025 $1,756

Food & beverage: $1,743Education: $14
CompanyPaymentsAmount
ABBVIE INC.32$622
Janssen Biotech, Inc.14$242
Takeda Pharmaceuticals U.S.A., Inc.9$137
Madrigal Pharmaceuticals6$106
Phathom Pharmaceuticals, Inc.9$100
Ipsen Biopharmaceuticals, Inc4$89
Aimmune Therapeutics, Inc.4$74
Gilead Sciences, Inc.3$67
Intercept Pharmaceuticals, Inc.4$63
GENZYME CORPORATION2$47

Products named: RINVOQ, TREMFYA, SKYRIZI, REZDIFFRA, VOQUEZNA, LINZESS, DUPIXENT, IQIRVO.

Industry payments across AR — which companies pay providers there.